Ma YT - Search Results

1

Ma YT, Cullen MH, Hussain SA. Ma YT, et al. Hematol Oncol Clin North Am. 2011 Jun;25(3):457-71, vii. doi: 10.1016/j.hoc.2011.03.004. Epub 2011 Apr 13. Hematol Oncol Clin North Am. 2011. PMID: 21570602 Review.

2

Management of metastatic germ cell tumors.

Hussain SA, Ma YT, Cullen MH. Hussain SA, et al. Among authors: ma yt. Expert Rev Anticancer Ther. 2008 May;8(5):771-84. doi: 10.1586/14737140.8.5.771. Expert Rev Anticancer Ther. 2008. PMID: 18471049 Review.

3

Biology of testicular germ cell tumors.

Hussain SA, Ma YT, Palmer DH, Hutton P, Cullen MH. Hussain SA, et al. Among authors: ma yt. Expert Rev Anticancer Ther. 2008 Oct;8(10):1659-73. doi: 10.1586/14737140.8.10.1659. Expert Rev Anticancer Ther. 2008. PMID: 18925857 Review.

4

Metastatic serous carcinoma of the testis: a case report and review of the literature.

Ma YT, Chaudhri S, Cullen MH. Ma YT, et al. Case Rep Oncol. 2011 Apr 18;4(1):246-9. doi: 10.1159/000327989. Case Rep Oncol. 2011. PMID: 21589850 Free PMC article.

5

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom.

Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D, Johnson PJ, Ross PJ. Palmer DH, et al. Among authors: ma yt. Br J Cancer. 2013 Aug 20;109(4):888-90. doi: 10.1038/bjc.2013.410. Epub 2013 Jul 23. Br J Cancer. 2013. PMID: 23880824 Free PMC article.

6

Evolution of systemic therapy for metastatic colorectal cancer.

Geh JI, Ma YT. Geh JI, et al. Among authors: ma yt. Colorectal Dis. 2011 Aug;13(8):852-4. doi: 10.1111/j.1463-1318.2011.02710.x. Colorectal Dis. 2011. PMID: 21762349 Review. No abstract available.

7

Impact of restricting access to high-cost medications for hepatocellular carcinoma.

Ma YT, Palmer DH. Ma YT, et al. Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):465-73. doi: 10.1586/erp.12.33. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 22971033 Review.

8

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.

Javed MA, Beyer G, Le N, Vinci A, Wong H, Palmer D, Morgan RD, Lamarca A, Hubner RA, Valle JW, Alam S, Chowdhury S, Ma YT, Archibugi L, Capurso G, Maisonneuve P, Neesse A, Sund M, Schober M, Krug S. Javed MA, et al. Among authors: ma yt. Pancreatology. 2019 Jan;19(1):97-104. doi: 10.1016/j.pan.2018.10.003. Epub 2018 Oct 15. Pancreatology. 2019. PMID: 30529068

9

Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.

Atkin C, Earwaker P, Pallan A, Shetty S, Punia P, Ma YT. Atkin C, et al. Among authors: ma yt. BMC Gastroenterol. 2017 Feb 14;17(1):30. doi: 10.1186/s12876-017-0585-x. BMC Gastroenterol. 2017. PMID: 28193171 Free PMC article. Review.

10

Association of Gastric Acid Suppression and Sorafenib Efficacy in Advanced Hepatocellular Carcinoma.

Razak RA, Fletcher P, Kunene V, Ma YT. Razak RA, et al. Among authors: ma yt. J Clin Gastroenterol. 2021 Feb 1;55(2):169-173. doi: 10.1097/MCG.0000000000001375. J Clin Gastroenterol. 2021. PMID: 32520885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page